Celyad Biosciences is a biopharmaceutical company
focused on the discovery, development and marketing of
regenerative and protective therapies for cardiovascular diseases.

Founded in 2007, it has patented a unique and
cutting edge technology to reprogram stem cells into heart cells
and is currently the most advanced company
in heart failure treatment.